Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturers:	Ribomustin Bendamustine hydrochloride 25mg equivalent to Bendamustine 22.7mg Powder for infusion Janssen-Cilag (New Zealand) Limited Cenexi-Laboratories Thissen SA, Braine-L’Alleud, Belgium Oncotec Pharma Produktion GmbH, Rosslau, Germany
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturers:	Ribomustin Bendamustine hydrochloride 100mg equivalent to Bendamustine 90.8mg Powder for infusion Janssen-Cilag (New Zealand) Limited Cenexi-Laboratories Thissen SA, Braine-L’Alleud, Belgium Oncotec Pharma Produktion GmbH, Rosslau, Germany

Dated this 8th day of May 2015.

CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Issue Number